Skip to main content
FinSpry Logo
FinSpry
CATX logo
CATX
(NYSEAMERICAN)
Perspective Therapeutics, Inc.
$2.95-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Perspective Therapeutics (CATX) Stock Price & Financial Analysis

Perspective Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.85 - $2.98
52-Week High$6.16
52-Week Low$1.96
Open$2.94
Volume582.37K
Average Volume (3M)2.16M
Market Cap219.96M
Shares Outstanding73.81M
Price to Sales (P/S)355.93
Price to Book (P/B)0.63
EV/EBITDA-1.49
Revenue (TTM)618.00K
Net Income (TTM)-111.13M
Free Cash Flow (TTM)-107.32M
EPS (TTM)$-1.50
Profit Margin-17982.69%
Operating Margin-19419.58%
Return on Equity (ROE)-31.99%
Debt to Equity0.02
50-Day MA$3.34
200-Day MA$3.57
52-Week Change-32.18%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Perspective Therapeutics

What is the current stock price for CATX?

As of the latest trading session, CATX stock trades at $2.95. The 52-week range is $1.96–$6.16, with a day range of $2.85–$2.98.

What is the P/E ratio for CATX?

The P/E ratio (Price-to-Earnings) for CATX is shown in the Key Statistics section. This valuation metric helps compare Perspective Therapeutics, Inc. to industry peers.

Does CATX pay dividends?

Perspective Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CATX?

Based on 8 analysts, the consensus for CATX is Buy.

What is the market cap of CATX?

Perspective Therapeutics's market capitalization is $217.7M, classifying it as a micro-cap company. Perspective Therapeutics operates in the Healthcare sector within the Medical Devices industry.